150 related articles for article (PubMed ID: 7070710)
1. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
Rossor MN; Svendsen C; Hunt SP; Mountjoy CQ; Roth M; Iversen LL
Neurosci Lett; 1982 Feb; 28(2):217-22. PubMed ID: 7070710
[TBL] [Abstract][Full Text] [Related]
2. The distribution and origin of glutamate decarboxylase and choline acetyltransferase in ventral pallidum and other basal forebrain regions.
Walaas I; Fonnum F
Brain Res; 1979 Nov; 177(2):325-36. PubMed ID: 497834
[TBL] [Abstract][Full Text] [Related]
3. Correlation of choline acetyltransferase activity between the nucleus basalis of Meynert and the cerebral cortex.
Koshimura K; Kato T; Yohyama I; Nakamura S; Kameyama M
Neurosci Res; 1987 Apr; 4(4):330-6. PubMed ID: 3601249
[TBL] [Abstract][Full Text] [Related]
4. Choline acetyltransferase and acetylcholinesterase containing projections from the basal forebrain to the amygdaloid complex of the rat.
Emson PC; Paxinos G; Le Gal La Salle G; Ben-Ari Y; Silver A
Brain Res; 1979 Apr; 165(2):271-82. PubMed ID: 311237
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus.
Candy JM; Perry EK; Perry RH; Bloxham CA; Thompson J; Johnson M; Oakley AE; Edwardson JA
Neurosci Lett; 1985 Oct; 61(1-2):91-5. PubMed ID: 4080261
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
Perry EK; Curtis M; Dick DJ; Candy JM; Atack JR; Bloxham CA; Blessed G; Fairbairn A; Tomlinson BE; Perry RH
J Neurol Neurosurg Psychiatry; 1985 May; 48(5):413-21. PubMed ID: 3998751
[TBL] [Abstract][Full Text] [Related]
7. Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea.
Aquilonius SM; Eckernås SA; Sundwall A
J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):669-77. PubMed ID: 125784
[TBL] [Abstract][Full Text] [Related]
8. Molecular forms of acetylcholinesterases in Alzheimer's disease.
Younkin SG; Goodridge B; Katz J; Lockett G; Nafziger D; Usiak MF; Younkin LH
Fed Proc; 1986 Dec; 45(13):2982-8. PubMed ID: 2430839
[TBL] [Abstract][Full Text] [Related]
9. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
Candy JM; Perry EK; Perry RH; Court JA; Oakley AE; Edwardson JA
Prog Brain Res; 1986; 70():105-32. PubMed ID: 3554348
[No Abstract] [Full Text] [Related]
10. Development of cholinergic markers in mouse forebrain. I. Choline acetyltransferase enzyme activity and acetylcholinesterase histochemistry.
Höhmann CF; Ebner FF
Brain Res; 1985 Dec; 355(2):225-41. PubMed ID: 4084778
[TBL] [Abstract][Full Text] [Related]
11. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease.
Etienne P; Robitaille Y; Wood P; Gauthier S; Nair NP; Quirion R
Neuroscience; 1986 Dec; 19(4):1279-91. PubMed ID: 3822122
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer dementia and reduced nicotinamide adenine dinucleotide (NADH)-diaphorase activity in senile plaques and the basal forebrain.
Jacobs RW; Farivar N; Butcher LL
Neurosci Lett; 1985 Jan; 53(1):39-44. PubMed ID: 3838807
[TBL] [Abstract][Full Text] [Related]
13. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.
Perry EK; Tomlinson BE; Blessed G; Bergmann K; Gibson PH; Perry RH
Br Med J; 1978 Nov; 2(6150):1457-9. PubMed ID: 719462
[TBL] [Abstract][Full Text] [Related]
14. Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain.
Armstrong DM; Bruce G; Hersh LB; Terry RD
Neurosci Lett; 1986 Nov; 71(2):229-34. PubMed ID: 2431362
[TBL] [Abstract][Full Text] [Related]
15. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
Whitehouse PJ
Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
[No Abstract] [Full Text] [Related]
16. Effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on visual discrimination acquisition, performance and reversal in the rat.
Evenden JL; Marston HM; Jones GH; Giardini V; Lenard L; Everitt BJ; Robbins TW
Behav Brain Res; 1989 Mar; 32(2):129-49. PubMed ID: 2923657
[TBL] [Abstract][Full Text] [Related]
17. Topographical projection of cholinergic neurons in the basal forebrain to the cingulate cortex in the rat.
Stewart DJ; MacFabe DF; Leung LW
Brain Res; 1985 Dec; 358(1-2):404-7. PubMed ID: 4075131
[TBL] [Abstract][Full Text] [Related]
18. Altered serotonergic and cholinergic synaptic markers in Pick's disease.
Sparks DL; Markesbery WR
Arch Neurol; 1991 Aug; 48(8):796-9. PubMed ID: 1898253
[TBL] [Abstract][Full Text] [Related]
19. Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor.
Haroutunian V; Kanof PD; Davis KL
Brain Res; 1986 Oct; 386(1-2):397-9. PubMed ID: 3779417
[TBL] [Abstract][Full Text] [Related]
20. Systematic regional differences in the cholinergic innervation of the primate cerebral cortex: distribution of enzyme activities and some behavioral implications.
Mesulam MM; Volicer L; Marquis JK; Mufson EJ; Green RC
Ann Neurol; 1986 Feb; 19(2):144-51. PubMed ID: 3963756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
